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Childhood leukaemias in New Zealand: time trends and ethnic differences
JD Dockerty, B Cox and MG Cockburn
Department ofPreventive and Social Medicine, University of Otago Medical School, PO Box 913, Dunedin, New Zealand.
Summary Registrations from the New Zealand Cancer Registry were used to examine time trends in the
incidence of leukaemias among children aged 0- 14. There was a statistically significant increase in the
incidence of leukaemia among children aged 0-4 during 1953-57 to 1988-90. In this age group, the recorded
incidence rate increased from 4.89 per 100 000 person -years in 1953 -57 to 7.92 in 1988 -90. During 1973 -77
to 1988-90 (and probably in earlier years), the increase was due to an increase in acute lymphoblastic
leukaemia (ALL). The trends were unlikely to be due to changes in diagnosis or case ascertainment. The
childhood leukaemia trends might be related to trends in family size, maternal age, socioeconomic level or
exposure to infections. However, there are uncertainties about the importance of these factors or about their
trends. The incidence of acute non-lymphoblastic leukaemia (ANLL) decreased between 1968-72 and 1988-
90. The time trends highlight the likely importance of environmental factors in the aetiology of childhood
leukaemias in New Zealand. The risk of ALL was lower in the Maori than in the non-Maori population
(relative risk Maori/non-Maori 0.74). The risk of ANLL was higher among Maori (relative risk 1.84).
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Information on the incidence of childhood leukaemias has
been collected by the New Zealand Cancer Registry since
1948. Until 1972, the Registry was mainly public hospital
based, but since then it has included registrations from
private hospitals, death certificates and autopsy reports
(Cooke et al., 1988). The Registry was regarded as being
truly population based from 1974 (Cooke et al., 1988).
Childhood leukaemias are serious diseases, and affected
children would usually have been admitted to hospital. Data
on completeness suggest that registration of lymphatic and
haematopoietic cancers was nearly complete from about
1953-55 (Medical Statistics Branch of the Department of
Health, 1955).
At the 1991 census, 14% of the childhood (ages 0-14)
residents of New Zealand were reported as being of solely
Maori ethnicity, and a further 7% were reported as being of
mixed New Zealand Maori ethnicity (Department of
Statistics, 1992). Children of sole Pacific Island ethnic
groups made up 5% of the total resident childhood
population (Department of Statistics, 1993a). Cancer
registration data for Maori are thought to have been more
closely related to sole Maori ethnicity than to mixed (plus
sole) Maori ethnicity (New Zealand Health Information
Service, 1995). 'Non-Maori' has been used in cancer registry
publications to refer to the rest of the population, which is
predominantly of British origin. Pacific Islanders form a
small part of the non-Maori population.
In a review of 49 countries, the highest age-standardised
incidence rate for childhood acute lymphoblastic leukaemia
(ALL) (ages 0- 14) was found in Costa Rica (4.5 per 100 000
person-years) (Parkin et al., 1988a). The rates of childhood
ALL in New Zealand were 3.2 per 100000 person-years
among non-Maori and 1.3 per 100 000 person-years among
Maori (Parkin et al., 1988a). New Zealand Maori had the
highest rate of childhood ANLL of any population studied
(Parkin et al., 1988b), while non-Maori New Zealanders had
the highest rate of any predominantly white population
(Parkin et al., 1988a).
Three studies of time trends in multiple countries have
included data from the New Zealand Cancer Registry, and
have given different results. Breslow and Langholz (1983)
found no significant trends in the incidence of childhood
leukaemia for Maori or non-Maori over 1962-66 to 1972-
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76. Draper et al. (1994) calculated the cumulative incidence of
combined childhood leukaemias among non-Maori as 66.0
(per 100 000) in 1972-76, with this decreasing to 62.1 in
1978-82, then increasing to 79.0 in 1983-87. Statistical tests
for trends were not presented. Coleman et al. (1993) found
that boys in New Zealand (but not girls) had a statistically
significant increase in the cumulative risk of childhood
leukaemia during the period 1965-85. The present study
examines the recorded incidence of childhood leukaemia in
New Zealand between 1948 and 1990.
Materials and methods
Childhood (ages 0- 14 years) leukaemia registrations were
obtained from the New Zealand Cancer Registry for each year
during 1948 -90. For the division into the different types [ALL,
acute non-lymphoblastic leukaemia (ANLL), other and
unspecified leukaemias] only the period 1968 -90 was used.
The International Classification of Diseases (ICD) codes used
for the leukaemia registrations in this study were decided after
discussions with haematologists and Cancer Registry staff, and
after referring to the literature. In classifying the leukaemias,
the aim was to ensure comparability across the time periods
studied. During 1948 -67, the combined leukaemias were
represented by the following ICD-7 codes: 204.0, 204.1,
204.2, 204.3 and 204.4. During 1968 -77, the different types
ofchildhood leukaemia were assigned to the following ICD-8
codes: ALL 204.0, 207.0 and 204.9; ANLL 205.0, 206.0 and
207.2; 'other and unspecified' 204.1, 205.1, 206.1, 206.9, 207.1
and 207.9. During 1978-87 (ICD-9) and 1988-90 (ICD-9
CM), the codes were: ALL 204.0, 204.8, 204.9 and 208.0;
ANLL 205.0, 206.0, 207.0, 207.2, 205.3 and 206.8; 'other and
unspecified' 204.1, 204.2, 205.1, 205.2, 205.8, 205.9, 206.1,
206.2, 206.9, 208.1, 208.2, 208.8 and 208.9. Childhood tumours
such as acuteunspecifiedleukaemiaswereclassified under acute
lymphoblastic leukaemia because of the high likelihood that
most were in this category in earlier years. The study was
restricted to children who had New Zealand residential
addresses at registration.
The correct birth date was available for 380 of the 444
children diagnosed between 1976 and 1987 as their birth
certificates were being used in another study. The ages of 27
children were changed on the basis of the more accurate
birthdates. For eight children (all with ALL), the change was
sufficient to alter which 5 year age group the child was in.
For one child, the corrected age was over 14 years, so theChildhood leukaemias in New Zealand
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child was excluded. For five of the eight, the corrections
shifted the age group from that of 5-9 to 0-4. For one, the
shift was from ages 10- 14 to ages 0-4, and for the
remaining child, the shift was from ages 10 -14 to 5-9.
The numbers of deaths from childhood leukaemia (1948-
90) were obtained from the New Zealand Health Information
Service (for 1948 and 1949); and from annual publications of
the Ministry of Health.
Annual mean population estimates, based on national
census data, were used for the calculation of age-specific and
age-standardised rates. Registration rates were calculated for
all the leukaemias combined (1948 -90); and for ALL,
ANLL, and other and unspecified leukaemias (1968 -90).
Five year age groups were used, and the standard was the
world standard population (Waterhouse et al., 1976). The
rates were calculated using pooled quinquennial periods,
except that the last period was truncated to 3 years (1988-
90). Rates were calculated for both sexes, Maori and non-
Maori, and the total population. For combined leukaemias
and ALL, the age group 0-4 was further subdivided, into
ages 'under 1 year' and '1 -4 years'. Trends in the
quinquennial age-specific and age-standardised rates, and
heterogeneity among the age-specific rates, were examined
(Mantel, 1963; Armitage and Berry, 1987). The 95%
confidence intervals for the age-standardised rates were
based on the binomial approximation (Armitage and Berry,
1987). Age-specific incidence rates were calculated for
individual years of age using pooled data (1981-90 for
ALL and 1968-90 for ANLL). Relative risks for sex and
ethnic group were also calculated, using pooled data from
1968-90. These were age-adjusted relative risks with 95%
confidence intervals, calculated using the formulae described
by Breslow (1984).
Results
The number of children registered with leukaemia of any type
during 1948-90 was 1409, among whom ALL (as defined in
Materials and methods) was the commonest type. Of the 851
registrations for leukaemias during 1968-90, 633 (74%) were
for ALL, 179 (21%) for ANLL and 39 (5%) for other and
unspecified leukaemias. Ninety-five per cent of those classified
as ALL had ICD codes corresponding to acute lymphatic or
acute lymphoid leukaemias. Five per cent had ICD codes
corresponding to other or unspecified lymphatic or acute
leukaemias. In the first 5 years (1948-52), the ratio of
registrations to deaths was 0.86 (Table I). In every other
period, registrations outnumbered deaths, and the ratio
increasedcontinually, from 1.03 in 1953 -57 to 2.62in 1988-90.
Trends in the incidence of combined leukaemias
In view ofthe incomplete registrations during 1948 -52 (Table
I), the presented results and the tests for trend for combined
leukaemias were restricted to the period 1953 -57 to 1988 -90.
There was a continued increase in the recorded incidence of
combined leukaemias during 1953 -57 to 1968 -72, then a drop
from 1968 -72 to 1973 -77, followed by a further increase from
1973 -77 to 1983 -87 (to ahigher rate than before), with similar
rates in 1983 -87 and 1988 -90 (Figure 1 and Table II).
In the total population, for all leukaemias combined, there
was a significant increase in the age-standardised rates
during 1953 -57 to 1988 -90 (P=0.02). The annual
percentage increase in the rate, relative to the average rate,
was 0.81% per year. There was significant heterogeneity
among the rates in the different age groups (P=0.02).
Children aged under 5 years had a highly significant increase
(P =0.0004), which explained the trend in the age-
standardised rates (Table II), while no overall trends were
found for children aged 5-9 and 10-14. The increase in
incidence for children under 5 years of age was present
among boys (P=0.01), girls (P=0.01), and non-Maori
(P =0.0003). For age groups 5-9 and 10- 14, there were
no overall trends in boys or girls or among non-Maori. For
Maori, there was no overall statistical trend in the rates
among those aged under 5 years, and for ages 5 -9 and 10-
14 there were too few Maori children with leukaemia to allow
interpretation of the trends.
Trends in the incidence of ALL and ANLL
Different trends in incidence were observed for ALL and
ANLL (Figure 1 and Table III). The age-standardised
incidence rate of ALL decreased from 1968-72 to 1973-77,
then increased steadily in each quinquennium until 1988-90
(the rates were 3.22, 2.74, 3.22, 3.67 and 4.10 per 100 000
person-years). The incidence of ANLL decreased steadily
between 1968-72 and 1978-82, then increased in 1983-87,
and decreased to a low point in 1988-90 (the rates were 1.13,
0.97, 0.78, 0.92 and 0.59 per 100 000 person-years).
For ALL, the trend tests showed that the increase in the
age-standardised rate was significant (1968-72 to 1988-90,
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Figure 1 Age-standardised registration rates for childhood
leukaemias in New Zealand, ages 0- 14. *, All leukaemias
combined; EI, acute lymphoblastic leukaemia; 0, acute non-
lymphoblastic leukaemia; 0, other and unspecified leukaemias.
Table I Childhood leukaemia registrations and deathsa in New Zealand, 1948-90: all leukaemias combined, for ages 0-14
Number of Ratio of
Timeperiod registrations Number of deaths registrations to deaths
1948-52 90 105 0.86
1953 -57 126 122 1.03
1958-62 151 144 1.05
1963 -67 191 160 1.19
1968-72 207 159 1.30
1973-77 175 134 1.31
1978-82 169 91 1.86
1983-87 190 104 1.83
1988 -90 110 42 2.62
aIn 1948, only non-Maori were included in the deaths. In all other years, Maori and non-Maori deaths were included.Childhood leukaemias in New Zealand
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Table II Childhood leukaemia registrations (numbers, and rates per 100000 person-years) in New Zealand, 1953-90: combined leukaemias
Age group (years)
0-4 5-9 10-14 0-14
Time period No. Rate No. Rate No. Rate No. Crude rate ASR (with 95% CI)
1953 -57 62 4.89 39 3.39 25 2.72 126 3.78 3.70 (3.41-3.99)
1958-62 71 4.93 53 4.13 27 2.30 151 3.88 3.84 (3.57-4.11)
1963-67 102 6.63 53 3.62 36 2.75 191 4.43 4.38 (4.11-4.66)
1968-72 103 6.91 57 3.69 47 3.19 207 4.59 4.64 (4.36-4.93)
1973-77 83 5.58 48 3.13 44 2.78 175 3.80 3.87 (3.61-4.12)
1978 -82 85 6.62 46 3.12 38 2.50 169 3.95 4.13 (3.85-4.41)
1983-87 100 7.92 43 3.33 47 3.18 190 4.71 4.87 (4.56-5.18)
1988-90 63 7.92 29 3.87 18 2.30 110 4.73 4.78 (4.38-5.18)
ASR, age-standardised rate; CI, confidence interval.
Table III Childhood leukaemia registrations (numbers and rates per 100000 person-years) by age, sex, and ethnic group, 1968-90:
by type of leukaemia
Age group (years) Sex Ethnic group
Leukaemia type, 0-4 5-9 10-14 0-14 Boys Girls Maori Non-Maori
time period No. Rate No. Rate No. Rate ASR No. ASR No. ASR No. ASR No. ASR
ALL
1968-72 72 4.83 46 2.98 25 1.69 3.22 79 3.49 64 2.94 21 3.80 122 3.14
1973-77 60 4.04 34 2.22 30 1.89 2.74 79 3.45 45 2.01 5 0.88 119 3.02
1978-82 71 5.53 36 2.44 23 1.51 3.22 78 3.76 52 2.66 13 2.41 117 3.34
1983 -87 81 6.42 31 2.40 30 2.03 3.67 90 4.58 52 2.71 13 2.63 129 3.83
1988-90 56 7.04 26 3.47 12 1.53 4.10 45 3.83 49 4.39 10 3.45 84 4.20
ANLL
1968-72 23 1.54 9 0.58 19 1.29 1.13 30 1.30 21 0.96 7 1.28 44 1.11
1973-77 19 1.28 12 0.78 13 0.82 0.97 24 1.03 20 0.90 8 1.40 36 0.90
1978-82 12 0.93 9 0.61 12 0.79 0.78 21 0.97 12 0.58 11 1.94 22 0.60
1983-87 15 1.19 8 0.62 14 0.95 0.92 18 0.87 19 0.97 10 1.91 27 0.77
1988-90 5 0.63 3 0.40 6 0.77 0.59 9 0.74 5 0.44 2 0.70 12 0.57
Other/unspecified
1968-72 8 0.54 2 0.13 3 0.20 0.29 9 0.40 4 0.18 2 0.36 11 0.28
1973-77 4 0.27 2 0.13 1 0.06 0.16 3 0.14 4 0.18 1 0.18 6 0.15
1978-82 2 0.16 1 0.07 3 0.20 0.14 4 0.19 2 0.08 2 0.40 4 0.10
1983-87 4 0.32 4 0.31 3 0.20 0.28 3 0.14 8 0.43 2 0.37 9 0.27
1988-90 2 0.25 0 0.00 0 0.00 0.09 1 0.08 1 0.09 1 0.35 1 0.05
ASR, age-standardised rate; ALL, acute lymphoblastic leukaemia; ANLL, acute non-lymphoblastic leukaemia.
linearity, although the rate during 1973-77 was lower than
the rates in adjacent time periods. The annual percentage
increase in the rate of ALL (1968-90), relative to the average
rate, was 2.2% per year. The increase in total leukaemias
among children aged under 5 years (Table II), at least during
1968-90, was due to a significant (P= 0.002) increase in ALL
for this age group (Table III). There were no overall trends in
ALL incidence for ages 5-9 or 10-14.
During 1968-72 to 1988-90, boys aged under 5 years had
a significant increase in incidence (P=0.04), and there was no
significant departure from linearity. Girls aged under 5 years
also had an increase in ALL incidence, but the trend was
significantly non-linear (the incidence rate was 4.7 per
100 000 person-years in 1968-72, 2.6 in 1973-77, 4.9 in
1978-82, 4.2 in 1983-87 and 8.0 in 1988-90). Non-Maori
aged under 5 years had a highly significant increase in the
incidence of ALL (P=0.004).
In the total population, there were too few children aged
under 1 year for the interpretation of time trends, though
ALL incidence rates for ages under 1 year increased steadily
in each quinquennium from 1968-72 to 1988-90. Children
aged 1-4 experienced a significant increase in the incidence
of ALL over the period (P=0.007).
For ANLL, there was a significant linear decrease in the
incidence rates (1968-72 to 1988-90; Figure 1 and Table
III). There was no significant heterogeneity among the
different age groups. The annual percentage decrease,
relative to the average rate, was 3.8% per year. In boys, no
overall trend in the age-standardised rates was found, and in
girls the trend tests could not be interpreted owing to small
numbers. Among non-Maori, there was a significant linear
decrease in the incidence of ANLL (P=0.02).
Age, sex and ethnic group
For ALL, the age distribution by individual years of age
showed a marked peak at ages 2-3 (the peak incidence rate
was 9.3 per 100 000 person-years). Sequential data for
combined leukaemias revealed that the size of the age peak
increased during 1953-90. The early ALL age peak was
marked for both Maori and non-Maori. The pooled (1968-
90) ALL registration rates for each 5 year age group (per
100 000 person-years) were: ages 0-4 Maori 6.0, non-Maori
6.6; ages 5-9 Maori 1.6, non-Maori 2.9; and ages 10-14
Maori 1.0, non-Maori 1.8. For ANLL, although the total
numbers were small, there were clearly high registration rates
at ages 0-2, with lower rates at ages 3-14 years.
Compared with girls, boys had a greater risk of both types
of leukaemia (statistically significant for ALL but not for
ANLL, Table IV). Maori had a lower risk of ALL and a
higher risk of ANLL than non-Maori (Table IV). The crude
relative risks (boys vs girls and Maori vs non-Maori) were
virtually identical to the age-adjusted relative risks.
Discussion
The most interesting finding was the clear increase in
leukaemia incidence rates for children aged 0-4 during
1953-57 to 1988-90 (Table II). During 1973-77 to 1988-
90 (and probably in earlier years), this was due to an increase
in ALL (Table III). The incidence of ANLL decreased during
1968-72 to 1988-90 (Figure 1, Table III). What are the
explanations for these trends? Underdiagnosis due to
masking by other causes of death such as pneumonia in theChildhood leukaemias in New Zealand
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Table IV Relative risks for sex and ethnicity, 1968-90: by type of leukaemia, for ages 0-14
Age-standardised Age-adjusted Age-standardised Age-adjusted
incidence rate relative risk incidence rate relative risk
per 100000 boys/girls per 100000 Maori/non-Maori
person-years (95% CI) person-years (95% CI)
Leukaemia type Boys Girls Maori Non-Maori
Acute lymphoblastic 3.95 2.90 1.36 (1.16-1.59) 2.65 3.56 0.73 (0.57-0.95)
Acute non-lymphoblastic 1.01 0.84 1.27 (0.94-1.70) 1.55 0.83 1.84 (1.29-2.62)
preantibiotic age (Stewart and Kneale, 1969) may have had
an effect on the accuracy of diagnosis in the early years, but
could not account for the continuation of the trends beyond
the introduction of antibiotics.
The childhood leukaemias in this study were classified into
three types (ALL, ANLL and 'other and unspecified'), based
on ICD site codes. Childhood cancers are better suited to
classifications based on morphology rather than site. The
Birch and Marsden (1987) classification separates the
childhood leukaemias into five types (acute lymphocytic,
other lymphoid, acute non-lymphocytic, chronic myeloid and
'other and unspecified'), based on ICD-O (oncology)
morphology codes. ICD-O codes have only been used by
the New Zealand Cancer Registry since 1978. Site-based
classifications were used in this study, and the aim was to
enable the two main types of childhood leukaemia (ALL and
ANLL) to be distinguished, from 1968 onwards.
Histological classification of the separate types of
leukaemia is considered to have been relatively accurate
since the late 1960s in New Zealand (personal communica-
tions from D Becroft, C Beresford and J Carter). There may
have been some under-reporting of the myeloid leukaemias,
because specialists might have expected children to have
lymphoid leukaemias and have classified them as such.
Misclassification is likely to have had a moderating effect
on the observed trends, rather than an effect that would lead
to spurious trends. If anything, one would have expected a
decrease in ALL and an increase in ANLL rather than the
converse, which has been found. The trends are therefore
unlikely to be related to changes in the diagnosis of the two
main types of childhood leukaemia.
Comparable analyses have shown that there were no
significant time trends in the registration rates of the
childhood non-Hodgkin's lymphomas in New Zealand
during 1953-90 (work in progress). Thus, the leukaemia
trends do not seem to be due to diagnostic shifts between
ALL and the non-Hodgkin's lymphomas.
One indication of the quality of a cancer registry is the
proportion of cases for which the diagnosis has a histological
basis, assuming that there is good completeness of
registration, and that the histology is accurate. During
1970-79, 100% of the children with ALL and ANLL on
the New Zealand Cancer Register had a histological basis for
diagnosis (Parkin et al., 1988a). There is no published
information on this for childhood leukaemias in earlier
periods.
The 5 year survival from childhood leukaemia in Britain
was very low (2%) for children diagnosed during 1954-63
(Birch et al., 1988), and is not likely to have been higher in
New Zealand at the time. The recording of more registrations
than deaths in 1953 -57 and in 1958-62 is evidence that case
ascertainment was nearly complete, even during those
periods. Thus, improvements in ascertainment do not
explain the trends. The subsequent increases in the ratio of
registrations to deaths (Table I) reflect improvements in
treatment over time.
Researchers from other countries have reported increases
in the incidence of ALL among children aged 0-4 or 1-4.
These include studies in Britain 1953-91 (Draper et al.,
1994); north-west England 1954-77 (Birch et al., 1980; Birch
et al., 1981); the Netherlands 1973-86 (temporary increase
1974-82) (Coebergh et al., 1989); and Connecticut 1935-79
(van Hoff et al., 1988). The data from north-west England
were recently updated to include 1954-88, and although
there was an overall increase for ages 0- 14, there were no
significant time trends for boys or girls aged 1-4 (Blair and
Birch, 1994). A study of childhood ALL in Baltimore 1960-
74 (Gordis et al., 1981) did not show an increase for children
aged 1-4. Two other studies (limited to all leukaemias
combined) have shown increases among young children,
including a study from Sweden 1958-74 (Ericsson et al.,
1978), and one from Denmark 1943-84 (de Nully Brown et
al., 1989). A study of combined leukaemias in upstate New
York (1969-80) did not record a significant change in
incidence among boys or girls aged under 5 years (Polednak,
1986). The New Zealand increase was one of the more
obvious secular trends among young children in latter
decades.
For childhood ANLL, temporal decreases in incidence
rates have been reported in two other studies: one in Britain
1962-91 (Draper et al., 1994), and another in Japan (Osaka)
1971 -88 (Ajiki et al., 1994). The decrease in Osaka may have
been partly due to changes in the diagnosis or classification
of ALL and ANLL, although the authors were of the
opinion that most of the leukaemia changes they observed
were real (Ajiki et al., 1994). Significant increases have been
reported in Queensland 1973-88 (McWhirter and Pet-
roeschevsky, 1991); and among black children in Baltimore
1965-74 (Gordis et al., 1981). Incidence rates of childhood
ANLL in the Netherlands 1973 -86 are reported to have been
relatively constant (Coebergh et al., 1989). In north-west
England 1954-88, there was no significant trend in the
incidence of childhood ANLL (Blair and Birch, 1994).
Relevance of time trends to aetiologicalfactors and hypotheses
ALL Because ALL was by far the commonest type, the
trends in combined leukaemias should mostly reflect trends in
the incidence of ALL. Up until 1953 (at least), childhood
leukaemia was 'rapidly and universally fatal', and mortality
and incidence were equivalent (Draper et al., 1994). If the
correct number of incident cases of childhood leukaemia for
1948-52 was 105 (deaths) and not 90 (registrations), the
crude incidence rate for 1948-52 would be 3.77 per 100 000
person-years, little different from 3.78 in 1953-57 (Table
II). The increase for young children in 1958-62 was minor,
but there were clear increases in 1963-67 and 1968-72
(Table II). Incidence dropped between 1968-72 and 1973-
77, then increased again in 1978-82 and 1983-87. Thus the
combined leukaemia results suggest that the incidence of
ALL in young children began to increase clearly in 1963-67.
The risks of childhood leukaemia from ionising radiation
exposure have been established (Doll, 1989). In New Zealand,
we have no nuclear power stations or reprocessing plants. A
study of childhood leukaemia incidence rates in Nordic
countries in relation to fallout from nuclear weapons testing
found no strong overall childhood leukaemia trends (Darby
et al., 1992). However, the rates of childhood leukaemia were
slightly higher in the late 1960s, when the effect would have
been greatest (Darby et al., 1992). Fallout from nuclear
weapons testing has been monitored in New Zealand by the
National Radiation Laboratory, and 'concentrations of
strontium-90 and caesium-137 in cows' milk peaked in 1965
..... and had decreased to the limits of detection by 1986',
(Matthews, 1994). Initially (after the 1965 peak), the average
half-life of each radionuclide was less than 2 years
(Matthews, 1994). If fallout had a material effect on
leukaemia in young children in New Zealand, it would beexpected to have led to a peak in incidence soon after 1965,
followed by a decline. Thus, the continued increase in the
incidence of childhood leukaemia in New Zealand does not
appear to be related to fallout.
Several case-control studies (and one cohort study) of
childhood leukaemia and electromagnetic field exposures
have been reported. While some have shown increased
risks, others have not, and no firm conclusions can yet be
drawn (Advisory Group on Non-ionising Radiation, 1992;
Ross et al., 1994). Detailed data on domestic electricity
consumption, supplied by Transpower New Zealand, showed
a remarkably consistent and continued increase in average
annual consumption from 2.5 megawatt hours (MWh) per
household in 1946 to 8.1 MWh in 1976. Domestic
consumption then reached a plateau, remaining between 7.1
and 7.9 MWh per household from 1977 to 1993. The
incidence of childhood ALL has followed a different course,
so it is unlikely that the leukaemia increases are related to
household consumption of electricity (a crude measure of
exposure to electromagnetic fields).
In a case-control study, Golding et al. (1990) reported
that babies given drugs (mainly vitamin K) in the neonatal
period had an increased risk of childhood cancer. Golding et
al. (1992) tested the association in a second study, finding a
doubling of the risk of childhood cancer in relation to
intramuscular vitamin K administration, but no elevation in
risk for oral administration. Three further studies of this issue
have not found elevated risks of childhood leukaemia
following vitamin K administration, including a cohort
study from Sweden (Ekelund et al., 1993), a nested case-
control study from the USA (Klebanoff et al., 1993) and a
descriptive study (of birth cohorts) from Denmark (Olsen et
al., 1994). According to the Department of Health,
intramuscular vitamin K had been available for use in
neonates in New Zealand since the late 1960s. (K Ronaldson,
personal communication). But vitamin K was given
routinely at National Women's Hospital, with 5000
deliveries per year as early as 1962 (R Howie, personal
communication). Thus, some of the New Zealand time trends
are consistent with the vitamin K hypothesis. The British
time trends for childhood leukaemia in relation to trends in
intramuscular vitamin K administration, on the other hand,
are probably not consistent with this hypothesis (Draper and
Stiller, 1992).
Childhood ALL has been associated with advanced
maternal age in some, but not all, studies (Ross et al.,
1994). The median age at which women had their first child
in New Zealand increased by 5.7 years between 1962 and
1993, compared with a rise of only 2.1 years for all mothers
(rather than new mothers) between these years (Statistics
New Zealand, 1995). However, these figures conceal the fact
that for all mothers there was a slight drop in the median
maternal age at delivery between 1962 and 1972, at which
point the increase began and continued until 1993 (Statistics
New Zealand, 1995). Thus, the later childhood leukaemia
trends (after the early 1970s), but not the earlier trends might
be consistent with increasing maternal age. However, an
effect of maternal age on childhood ALL risks has not been
observed consistently in analytical studies, and the overall
change in the age of New Zealand mothers has not been
large. Changes in maternal age do not seem to offer a
sufficient explanation for the increase in the incidence of
childhood ALL observed in this study.
Several studies (but not all) have reported a higher risk of
childhood leukaemia for firstborn children (Ross et al., 1994).
The proportion of firstborn children in the population is
likely to have increased as family sizes have decreased.
Family size in New Zealand increased in the post war years;
there was a peak in the total fertility rate in 1961, then a
decline until 1983, followed by a small increase (Department
of Statistics, 1993b). Between 1976 and 1991, the average size
of the New Zealand household declined from 3.2 to 2.8
members (Public Health Commission of New Zealand, 1993).
Thus, if there is a real association between birth order and
Childhood leukaemias in New Zealand
JD Dockerty et al x
1145
childhood leukaemia, one might expect to have seen an
increase in incidence rates beginning after the 1961 peak in
the fertility rate. The results of this study have suggested that
the incidence of childhood leukaemia probably began to
increase in about 1963-67. Thus, the trends in family size
may at least partly explain the increase in the incidence of
childhood leukaemia.
Studies of the relationship between social class and
childhood leukaemia have not been consistent, but some
have found an increased risk among higher social classes
(Draper and Elliott, 1991). Social class is a complex concept
involving such factors as employment, housing, income and
education. A detailed analysis of time trends in social class
(and its component factors) is beyond the scope of the
present work, but such work would be useful, as temporal
changes in socioeconomic level could have a bearing on the
leukaemia trends.
Kinlen (1988) hypothesised that childhood leukaemia
occurs as a rare response to a common infection, and that
population influxes into areas of low herd immunity favour
the occurrence of epidemics of the infection, and increases in
leukaemia incidence. If a virus that could cause childhood
leukaemia was introduced into New Zealand, and if more
and more people gradually became infected, one might expect
to see an increase in incidence rates. But Kinlen's hypothesis
has been tested mainly in relation to local population
movements, and the hypothesis cannot be confirmed or
refuted by this study of national time trends.
Greaves and Chan (1986) hypothesised that spontaneous
mutations in B-cell precursors could account for the majority
of cases of ALL. The clear and continued increases in the
incidence of ALL among children aged under 5 years, but not
among older age groups, argue against this spontaneous
mutation hypothesis in its pure form. Greaves (1988)
elaborated the hypothesis by suggesting that two genetic
events, both spontaneous mutations, were needed to produce
common (B-cell precursor) ALL. The first event was
hypothesised to occur in utero (following developmentally
driven proliferative stress on B-cell precursors), and the
second in infancy, (following proliferative stress resulting
from exposure to exogenous antigens) (Greaves, 1988).
Greaves suggested that the incidence of ALL was associated
with a certain pattern of exposure to infections and other
antigens; such exposure would be affected by socioeconomic
circumstances, and the responses to exposure would be
modulated by genetic background, duration of breastfeeding
and vaccinations (Greaves, 1988). The weak associations of
common ALL with higher socioeconomic level and firstborn
children could be due to delayed exposure to infections,
leading to more proliferative stress (Greaves, 1988). A
corollary of all this (if the hypothesis is correct) is that
temporal changes in the factors related to the exposure of
infants to antigens could lead to secular time trends. During
the period of this study, there have been changes in
breastfeeding, vaccinations, socialisation, education, family
structure and income. The effect of this mixture of changes
(in terms of Greaves' hypothesis) is complicated, and it is not
practical to offer a simple interpretation of the ALL time
trends in relation to it. Some factors relevant to Greaves'
hypothesis (and infections in general) would also be relevant
to certain specific infections.
Acute non-lymphoblastic leukaemia In adults, there is strong
evidence that benzene exposure can cause ANLL (Austin et
al., 1988). It is not known whether this is also the case for
children. There are no long-term time trend data on the
exposure of New Zealanders to benzene.
Age and ethnic group
This study confirms previous work by Gunz (1966), who
identified a peak in the age distribution of childhood acute
leukaemias at ages 2-3. The present work showed that the
peak increased in size, in tandem with the increase in thecmi,o.d ra
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incidence of ALL for young children. A similar peak
developed in Britain in the 1920s and 1930s (Neglia and
Robison, 1988) and increased in size between 1931 and 1953
(Hewitt, 1955). After 1940, there was an increase in the age
peak among US Whites (Court Brown and Doll, 1961). The
early age peak has not been found in tropical Africa, even
when an intensive search for cases of ALL has been made
(Fleming, 1988). The early age peak is due to common ALL
(Greaves et al., 1981; 1985).
In New Zealand health statistics, ethnicity is not assigned
in a uniform way, leading to possible bias because of
differences in the ways numerator and denominator data
are collected and classified (Brown, 1983; Smith and Pearce,
1984; Review Committee on Ethnic Statistics, 1988). In this
study, population estimates were based on the national
census. The census currently relies on self-identification of
ethnic group. The registration data come mainly from
hospitals. In hospital admission records, ethnicity could be
assigned on the basis either of self/parent-identification or of
observation by the admitting staff. It is not possible to
properly assess the validity of the rates, trends and
comparisons that involve ethnic groups. The long time
period of this study makes such assessments very difficult,
because of the likelihood of temporal changes in the
comparability of the numerator and denominator data for
Maori and non-Maori.
The lower rates of ALL (and higher rates of ANLL)
among Maori than non-Maori may be due to genetic
differences that affect susceptibility to ALL, or to causes of
it. Alternatively (or additionally), lifestyle or environmental
differences might result in differences in exposure to risk
factors. Compared with the total New Zealand population,
Maori have on average greater unemployment, lower income,
fewer educational qualifications, higher levels of overcrowd-
ing in homes and lower levels of home ownership (Public
Health Commission of New Zealand, 1994).
It is of interest to compare the incidence rates for New
Zealand Maori with those found in a previous study of
another Polynesian population. Goodman et al. (1989)
calculated the incidence of childhood ALL (ages 0-14)
among Hawaiians in Hawaii, 1960-84. Their rates (per
100 000 person-years) were 2.5 for Hawaiian boys and 2.1
for Hawaiian girls, based on small numbers (19 girls and 14
boys). New Zealand Maori had a similar incidence rate for
ALL (2.5 per 100 000 person-years for both sexes combined,
1968-90).
The temporal changes in the incidence rates of ALL and
ANLL in New Zealand highlight the likely importance of
environmental factors in the aetiology of these cancers in
children.
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